ArticleJournal of molecular medicine (Berlin, Germany)2017

Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Bonan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.